Internal link ProQR Announces R&D Day and Provides Update on Innovation Portfolio Novembro 30, 2015 at 12:00 PM UTC
Internal link ProQR Announces Results for the Third Quarter of 2015 and Provides Update on Clinical Trials Novembro 23, 2015 at 11:30 AM UTC
Internal link ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences Outubro 01, 2015 at 11:00 AM UTC
Internal link ProQR to Present at the Leerink Partners 4th Annual Rare Disease Roundtable Setembro 23, 2015 at 11:00 AM UTC
Internal link ProQR Announces a Proof-of-Concept Nasal Potential Difference Study of QR-010 is Open for Enrollment Setembro 14, 2015 at 11:00 AM UTC
Internal link ProQR Announces Enrollment Has Started in Global Phase 1b Study of QR-010 in Cystic Fibrosis Patients Junho 26, 2015 at 11:54 AM UTC
Internal link ProQR to Present at the JMP Securities Life Science Conference Junho 16, 2015 at 11:00 AM UTC
Internal link ProQR Therapeutics Announces Results for the First Quarter of 2015 Maio 21, 2015 at 11:00 AM UTC
Internal link ProQR to Present at Two Upcoming Investor Conferences in May Abril 29, 2015 at 11:00 AM UTC
Internal link ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014 Fevereiro 26, 2015 at 12:00 PM UTC
Internal link ProQR to Present at the 2015 Leerink Global Healthcare Conference Fevereiro 04, 2015 at 12:00 PM UTC